eli lilly &amp co hypnion deal will aid sleep disorder research eli lilly &amp co agreed to acquire hypnion inc a closely held neuroscience drug discovery company that focuses on sleep disorders financial terms werent disclosed hypnion based in lexington mass is developing a compound called hy which is of particular interest to lilly according to a spokesman for the indianapolis drug maker the compound is undergoing testing and hasnt received approval from the food and drug administration lilly also is reviewing sleep trial data for its own insomnia drug a compound called pruvanserin the spokesman said the company hopes to use it to treat central nervous system disorders like depression hypnion employs people lilly employed as of dec 
